Galectin-3 as a marker and potential therapeutic target in breast cancer
about
Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectivesOverexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical CancerGalectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.Clinical implications of transforming growth factor-beta-induced gene-h3 protein expression in lung cancer.Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.Retrospective Proteomic Screening of 100 Breast Cancer Tissues.Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5.Methods for the detection and serum depletion of porcine galectin-3.Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).The emerging role of galectins in high-fatality cancers.
P2860
Q26742115-76FAFA6D-3B10-4B81-9087-94461E878280Q26775315-C056636F-C705-4D9D-B7E4-0F18F81DF480Q33653371-8F9756C5-AE79-46ED-820B-4CAC2E1A277BQ35661292-74818496-8BD7-443F-8DAC-F9AC2D94AC6EQ36208118-AFDE8C0F-2B5E-4FE8-8A7D-02B292CEEC0CQ37179418-37E31DFA-4E82-4B6C-B8ED-ADAD6B3EAFA1Q37299331-FDBCFA18-7E57-4F6C-96AA-085ED440696BQ38689543-98C16F77-A18C-49A9-851D-4D86A5EACFA4Q43119413-5849ADFE-23E5-4A4B-BA68-FFD93EB1D5B8Q44638329-5F1A8987-0612-4A5F-B8E2-1E53D5C270F2Q45884221-7518D9B4-F532-4BC2-9716-6AFB6035DF90Q45992912-834814A1-103B-49C9-90FF-79F9BE7B7D53Q46209871-1364950B-F282-45BC-91EE-5CB6279ABFA7Q47329197-1533748C-BC5B-433D-92E5-BEAB8E057E0FQ50101341-87231426-84CF-47F1-A740-F76FFD21C466
P2860
Galectin-3 as a marker and potential therapeutic target in breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Galectin-3 as a marker and potential therapeutic target in breast cancer
@ast
Galectin-3 as a marker and potential therapeutic target in breast cancer
@en
Galectin-3 as a marker and potential therapeutic target in breast cancer
@nl
type
label
Galectin-3 as a marker and potential therapeutic target in breast cancer
@ast
Galectin-3 as a marker and potential therapeutic target in breast cancer
@en
Galectin-3 as a marker and potential therapeutic target in breast cancer
@nl
prefLabel
Galectin-3 as a marker and potential therapeutic target in breast cancer
@ast
Galectin-3 as a marker and potential therapeutic target in breast cancer
@en
Galectin-3 as a marker and potential therapeutic target in breast cancer
@nl
P2093
P2860
P1433
P1476
Galectin-3 as a marker and potential therapeutic target in breast cancer
@en
P2093
Guanglei Chen
Xinhan Zhao
Zuowei Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0103482
P407
P577
2014-09-25T00:00:00Z